The CardioTag device fuses multiple sensing modalities to capture unique insights about the relationship between cardiac mechanics, electrical impulses, and blood flow – valuable inputs that can be used by AI algorithms to assess cardiac pressures and volume status CHICAGO–July 29, 2025–Cardiosense, a medical AI company transforming cardiovascular disease management, […]
Rhythm
Stereotaxis Receives U.S. FDA Clearance for MAGiC Sweep Catheter
ST. LOUIS, July 28, 2025 (GLOBE NEWSWIRE) — Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its groundbreaking MAGiC Sweep™ catheter. MAGiC Sweep is the world’s first robotically navigated high-density electrophysiology (EP) mapping catheter, representing a significant advancement in the technology available to diagnose and treat complex arrhythmia patients.
Philips announces collaboration with Epic to enhance ambulatory cardiac monitoring
July 24, 2025
Vektor Medical’s vMap Surpasses 2,000 Procedures, Driving a New Standard in Arrhythmia Care
SAN DIEGO–(BUSINESS WIRE)–Vektor Medical today announced its vMap® system has been used in more than 2,000 procedures in the U.S., a milestone that underscores its rapid adoption by electrophysiologists (EPs) and hospitals seeking to improve procedural efficiency, reduce repeat interventions, and deliver better patient outcomes. As adoption of PFA accelerates, the need […]
HeartBeam Wins Industry Innovation Award for Advancing Remote Cardiac Care With Groundbreaking ECG Technology
FDA-cleared technology makes clinical-grade ECG insights for arrhythmia assessment available outside of a medical facility SANTA CLARA, Calif.–(BUSINESS WIRE)–HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful personalized insights, today announced it has been awarded the Innovation Award in Remote Cardiac Diagnostics as part […]
MFDS Clears DeepQure’s HyperQure™ for Clinical Trial in Atrial Fibrillation
SEOUL, South Korea, July 17, 2025 /PRNewswire/ — DeepQure announced today that South Korea’s Ministry of Food and Drug Safety (MFDS) has approved a clinical trial of HyperQure™ RDM System, the company’s novel laparoscopic renal denervation (RDN) system, for the treatment of atrial…
Octagos Selected as a Cardiac Remote Monitoring Company in Microsoft for Startups Pegasus Program
HOUSTON, July 17, 2025 /PRNewswire/ — Octagos, one of the fastest-growing remote cardiac monitoring platforms, today announced its selection for the Microsoft for Startups Pegasus Program – an elite, invite-only initiative for high-growth startups advancing innovation in AI, healthcare,…
Philips Launches ECG AI Marketplace to Enhance Early Cardiac Diagnosis
July 17, 2025
Johnson & Johnson Receives FDA Approval for Updated VARIPULSE™ Platform Irrigation Rate
New flow rate guidance designed to optimize irrigation and support consistent procedural outcomes 10,000+ VARIPULSE global procedures with low adverse event rate reinforces platform’s strong safety profile New Brunswick, NJ – July 14, 2025 – Today, Johnson & Johnson MedTech, a global leader in cardiac arrhythmia treatment, announced U.S. Food and Drug […]
Catheter Precision, Inc. Announces First Purchase Order From University Hospital in Rennes, France
FORT MILL, S.C., July 07, 2025 (GLOBE NEWSWIRE) — Catheter Precision, Inc. (VTAK – NYSE/American), a US based medical device company focused on developing technologically advanced products for the cardiac electrophysiology market announced today that it has received a purchase order from Centre Hospitalier Universitaire (CHU) de Rennes. This is the first purchase order from Universite de Rennes and marks the largest purchase order for the VIVO product line to date.


